Clin2
NCT07505043Possibly a fitNot yet recruiting

Study of a new drug for safety and how it works in the body

Healthy SubjectsHyperlipidemia, Hypertriglyceridemia

Part of Hormones & metabolism clinical trials.

This trial tests a new medicine called ISH0688 for safety and how the body processes it. It has two parts: one in healthy volunteers and one in people with high triglycerides, to see if the drug can help lower fats in the blood.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
104 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You must be between 18 and 75 years old (depending on part of study).
  • You must have a certain weight and body mass index (BMI) that fits study rules.
  • You must agree to use birth control if you could become pregnant or get someone pregnant.
  • You must not have certain health problems like severe liver disease or a history of pancreatitis.
  • If in part 2, you must have high triglycerides and be willing to have liver fat measured by an MRI.
  • You must stop taking certain other medications or supplements that affect blood fats, as directed.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07695597Recruiting· Phase 2
Study of SYH2070 for people with high cholesterol and triglycerides

This trial tests an investigational injection called SYH2070 to lower cholesterol and triglycerides in people who are already on a stable statin therapy. It may be a new option for those with mixed hyperlipidemia who need additional lipid control.

Hangzhou, Zhejiang
NCT07349615Recruiting· Phase 3
Study of SHR-1918 for high triglycerides

This trial tests a new medication, SHR-1918, to lower high triglyceride levels. It may be an option for people with moderately elevated triglycerides and controlled cholesterol.

Shanghai, Shanghai Municipality
NCT07777003Not yet recruiting· Phase 1
Study of a new drug for mild high cholesterol

This trial tests a new drug called HS-10582 in healthy people and those with slightly high LDL cholesterol (a type of cholesterol). The goal is to see if it is safe and how well your body handles it.

NCT07766759Not yet recruiting· Phase 1
Study of an experimental drug for adults with high triglycerides

This early-phase trial tests an experimental drug called FXR0906 in healthy adults who have elevated triglycerides (a type of fat in the blood). It aims to see if the drug is safe and how it affects cholesterol and fat levels, which may help prevent heart disease.

Beijing, Beijing Municipality
NCT07241923Recruiting· Phase 1
SYH2070 injection safety study for high triglycerides and high cholesterol

This study tests a new injection called SYH2070 for people with high triglycerides and high LDL cholesterol. The goal is to see if a single dose is safe and how the body processes the medication. It is for people who have not been on cholesterol-lowering drugs recently.

Shijiazhuang, Hebei
NCT07776041Not yet recruiting· Phase 1
Study of a new injection for healthy volunteers

This trial tests a new injection called SYH2092 in healthy adults, not for treating a disease. Participation helps researchers understand how the drug works in the body and if it is safe. If you qualify, you may be compensated for your time.

Melbourne, Victoria

Hear when a new Healthy Subjects trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.